Phase 4 Autoimmune Clinical Trials
7 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–7 of 7 trials
Recruiting
Phase 4
Taper Or Abrupt Steroid Stop: TOASSTtrial
AutoimmuneInflammatory Disorder
University Hospital, Basel, Switzerland530 enrolled16 locationsNCT03153527
Recruiting
Phase 4
Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases
Autoimmune Rheumatologic Disease
University of Sao Paulo General Hospital263 enrolled2 locationsNCT07252804
Recruiting
Phase 4
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators
Autoimmune Rheumatic Diseases
University of Sao Paulo General Hospital200 enrolled1 locationNCT07280741
Recruiting
Phase 4
Safety and Immunogenicity of PCV20 in Pediatric Patients With Autoimmune Rheumatic Diseases
Autoimmune Rheumatologic Disease
University of Sao Paulo General Hospital114 enrolled1 locationNCT07252791
Recruiting
Phase 4
Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
Dry EyeAutoimmune DiseasesNeurotrophic Keratitis
Toyos Clinic20 enrolled1 locationNCT06964269
Recruiting
Phase 4
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
Postpartum HemorrhageSystemic Autoimmune Diseases
RenJi Hospital276 enrolled1 locationNCT06754371
Recruiting
Phase 4
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease
PreventionAutoimmune DiseasesConnective Tissue Disease+2 more
Tongji Hospital800 enrolled1 locationNCT06499233